• English
  • Sign In
  • Contact Us
×
Webinars » Development of a Potential Recombinant Protein Vaccine in E. Coli

Development of a Potential Recombinant Protein Vaccine in E. Coli

Recombinant proteins can be powerful stimulators of the immune system making them good candidates for vaccines. Using the intracellular parasite, Leishmania donovani as an example, this webinar will take you through the steps required for development and testing of a recombinant vaccine.

In this talk you will learn how to:

  • Express and purify protein from bacteria
  • Use the "High 3" mass spectrometry method to monitor process
  • Test the immunogenicity of the recombinant protein
Development of a Potential Recombinant Protein Vaccine in E.coli
HTP Gene to Antibody Production BacPower™ Guaranteed Bacterial Protein Expression Services HD Transient Expression Service
  • 50 μg or 1 mg packages
  • Starting under $500
  • Rapid turnaround - 6 weeks
  • Ideal for Ab screening application, epitope binning, assays, and HTP biophysical characterization studies
  • Gene synthesis included in package
  • Guaranteed amount of recombinant protein – no cost to you if project fails.
  • Guaranteed purity of recombinant protein
  • Competitive price - starting from $1600.
  • Fast turnaround time - as little as 4 weeks.
  • Ideal for in vitro applications
  • HD-HEK and HD-CHO for choice of HEK293 or CHO expression
  • Yield improvements ranging up to 100 fold
  • Shortened turnaround time (sequence to protein/antibody in as little as 10 weeks)
  • Ideal for difficult and low-yield proteins and for need of proteins with proper folding and appropriate post-translational modifications